PGEN - Precigen Inc logo

PGEN

Precigen Inc

Precigen, Inc. develops gene and cell therapies focused on immuno-oncology, autoimmune disorders, and infectious diseases. Its platforms include AdenoVerse for gene delivery and UltraCAR-T for chimeric antigen receptor T cell therapies for cancer.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$244today

Score Overview

1 Year
Score
Net Growth37.08%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth8x
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.2
Net Growth-71.11%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth6x
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth15.49%
Net Trend50%
Net Income Consistency
Rev Growth-55.10%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-304.58%
Net Trend38%
Net Income Consistency
Rev Growth260.76%
Rev Trend54%
Revenue Consistency

See the full market ranking โ†’

Precigen Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 31M to $ 9M and net income went from -$ 170M to -$ 250M. Revenue increased in 3 of those 5 years; net income in 2.

Between 2015 and 2025, revenue declined from $ 173M to $ 9M and net income went from -$ 84M to -$ 250M. Revenue increased in 4 of those 10 years; net income in 5.

Precigen Inc currently holds a 5-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.85โ€”
1 Year2025-08-12
$ 1.80280.56%
5 Years2021-08-12
$ 6.1211.93%
10 Years2016-08-12
$ 28.02-75.55%
All Time2013-08-08
$ 23.63-71.02%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 85M-$ 157M$ 38M
2025$ 9M-$ 250M$ 97M
2024$ 3M-$ 126M$ 97M
2023$ 6M-$ 95M$ 62M
2022$ 26M$ 28M$ 55M
2021$ 14M-$ 92M$ 108M
2020$ 31M-$ 170M$ 100M
2019$ 31M-$ 170M$ 75M
2018$ 160M-$ 509M$ 222M
2017$ 230M-$ 117M$ 79M
2016$ 190M-$ 186M$ 237M
2015$ 173M-$ 84M$ 238M
2014$ 71M-$ 81M$ 115M
IPO2013$ 23M-$ 38M$ 177M

Explore beyond PGEN

You're looking at Precigen Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies